Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 49501-49550 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05466331
Rural New England Health Study (Phase 2)
NA
Recruiting
220 participants
Started: May 18, 2022 · Completed: Jul 31, 2024
3 conditions
7 sponsors
3 locations
NCT05528055
A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors
PHASE1
Recruiting
122 participants
Started: May 18, 2022 · Completed: Oct 31, 2027
2 conditions
1 sponsor
1 location
NCT05404048
PD-L1 PET-imaging During CAR T-cell Therapy
PHASE2
Recruiting
20 participants
Started: May 18, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05540834
Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
PHASE2
Recruiting
70 participants
Started: May 18, 2022 · Completed: Dec 1, 2026
3 conditions
1 sponsor
1 location
NCT05918991
Interventions for English Language Learners At-Risk for ADHD
NA
Recruiting
300 participants
Started: May 18, 2022 · Completed: Jul 30, 2026
1 condition
4 sponsors
1 location
NCT05182372
Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities
NA
Recruiting
600 participants
Started: May 18, 2022 · Completed: Aug 30, 2026
1 condition
3 sponsors
1 location
NCT05531799
Anal HSIL Screening Algorithm
NA
Recruiting
950 participants
Started: May 18, 2022 · Completed: Dec 30, 2029
1 condition
3 sponsors
1 location
NCT04833023
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial
PHASE3
Recruiting
72 participants
Started: May 18, 2022 · Completed: Dec 31, 2024
5 conditions
1 sponsor
3 locations
NCT06182787
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
N/A
Recruiting
130 participants
Started: May 18, 2022 · Completed: Oct 18, 2024
9 conditions
1 sponsor
1 location
NCT05510401
Evaluation of Safe Use of SECURIDRAP® SELFIA®
NA
Recruiting
108 participants
Started: May 18, 2022 · Completed: Jul 30, 2025
3 conditions
2 sponsors
10 locations
NCT05600088
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina
NA
Recruiting
30 participants
Started: May 18, 2022 · Completed: Jul 31, 2026
6 conditions
2 sponsors
5 locations
NCT05472792
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
PHASE2
Recruiting
90 participants
Started: May 17, 2022 · Completed: Apr 15, 2032
2 conditions
1 sponsor
1 location
NCT06116630
StrokeCog-BBB to Study Cognitive Outcomes Following Stroke
N/A
Recruiting
350 participants
Started: May 17, 2022 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT04469504
Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer
NA
Recruiting
158 participants
Started: May 17, 2022 · Completed: May 31, 2028
2 conditions
3 sponsors
1 location
NCT05337982
Eccentric Muscle Training, Stimulation, and Biomarkers in SCI
NA
Recruiting
49 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
2 conditions
4 sponsors
2 locations
NCT05384496
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
PHASE2
Recruiting
20 participants
Started: May 17, 2022 · Completed: May 31, 2026
1 condition
2 sponsors
2 locations
NCT05289076
Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model
PHASE1/PHASE2
Recruiting
40 participants
Started: May 17, 2022 · Completed: Mar 14, 2025
4 conditions
3 sponsors
1 location
NCT05206500
NextGen - Clinical Implication of Next Generation Sequencing
PHASE4
Recruiting
100 participants
Started: May 17, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05271318
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a and 2) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.
PHASE1/PHASE2
Recruiting
76 participants
Started: May 17, 2022 · Completed: Aug 31, 2027
9 conditions
2 sponsors
4 locations
NCT05210413
Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults
PHASE1/PHASE2
Recruiting
59 participants
Started: May 17, 2022 · Completed: Nov 17, 2027
1 condition
4 sponsors
9 locations
NCT05346484
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors
PHASE1
Recruiting
100 participants
Started: May 17, 2022 · Completed: Nov 30, 2026
7 conditions
1 sponsor
12 locations
NCT05918536
Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality
N/A
Recruiting
45 participants
Started: May 17, 2022 · Completed: Nov 17, 2025
2 conditions
3 sponsors
1 location
NCT05294185
Intra-operative Hyperspectral Imaging in Neurosurgery
N/A
Recruiting
81 participants
Started: May 17, 2022 · Completed: Aug 31, 2024
3 conditions
1 sponsor
1 location
NCT05670093
Neural Pressure Support, Synchrony and Respiratory Muscle Unloading
NA
Recruiting
22 participants
Started: May 17, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT05114798
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
NA
Recruiting
255 participants
Started: May 17, 2022 · Completed: Aug 31, 2027
4 conditions
2 sponsors
1 location
NCT05203965
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant
EARLY_PHASE1
Recruiting
80 participants
Started: May 17, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT05219058
Reconstruction in Extended MArgin Cancer Surgery
N/A
Recruiting
236 participants
Started: May 17, 2022 · Completed: Jan 1, 2028
4 conditions
18 sponsors
18 locations
NCT05091957
Connecting Families
NA
Recruiting
80 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06245876
Lung EpiCheck Biomarkers Development Study
N/A
Recruiting
6,000 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
10 locations
NCT05382377
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
EARLY_PHASE1
Recruiting
18 participants
Started: May 17, 2022 · Completed: May 17, 2026
2 conditions
2 sponsors
1 location
NCT05472311
Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation
NA
Recruiting
565 participants
Started: May 17, 2022 · Completed: Nov 30, 2026
1 condition
3 sponsors
1 location
NCT05432453
The Relationship Between Functional Constipation and Sacroiliac Joint Dysfunction
N/A
Recruiting
128 participants
Started: May 16, 2022 · Completed: May 1, 2024
2 conditions
1 sponsor
1 location
NCT05623514
Ultrasound Evaluation for Improving Patient Selection in vNOTES
NA
Recruiting
75 participants
Started: May 16, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05375266
Immune Biomarker Study for Head and Neck Cancer
N/A
Recruiting
1,100 participants
Started: May 16, 2022 · Completed: Mar 31, 2027
5 conditions
4 sponsors
3 locations
NCT05256160
Cortical Excitability in Cyclic Vomiting Syndrome
NA
Recruiting
110 participants
Started: May 16, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05388747
Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in Neonates
N/A
Recruiting
100 participants
Started: May 16, 2022 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT05414162
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
N/A
Recruiting
60 participants
Started: May 16, 2022 · Completed: Dec 31, 2025
9 conditions
1 sponsor
1 location
NCT06683339
Functional Capacity in Children with Chronic Kidney Disease
N/A
Recruiting
26 participants
Started: May 16, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT04893564
Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia
NA
Recruiting
90 participants
Started: May 16, 2022 · Completed: Jul 31, 2028
2 conditions
5 sponsors
1 location
NCT06566872
Collecting Recorded Videos of Colonoscopy and Gastroscopy Tests for the Evaluation of the (ME-APDS).
N/A
Recruiting
700 participants
Started: May 16, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05199454
Role of Adiposomes in Endothelial Dysfunction
NA
Recruiting
60 participants
Started: May 16, 2022 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT05641662
Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
NA
Recruiting
750 participants
Started: May 16, 2022 · Completed: Apr 30, 2027
1 condition
1 sponsor
10 locations
NCT05269368
Interest of Wicking for Ossicular Surgery and Myringoplasty
NA
Recruiting
150 participants
Started: May 16, 2022 · Completed: May 16, 2026
2 conditions
1 sponsor
6 locations
NCT05755919
Functional Brain Mapping for Patients with Epilepsy
NA
Recruiting
80 participants
Started: May 16, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
2 locations
NCT03936478
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
PHASE2
Recruiting
30 participants
Started: May 16, 2022 · Completed: Jan 31, 2031
3 conditions
1 sponsor
1 location
NCT05331937
TMS for Exposure Therapy Resistant OCD
PHASE3
Recruiting
250 participants
Started: May 16, 2022 · Completed: Sep 1, 2027
2 conditions
7 sponsors
8 locations
NCT07087964
Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients
N/A
Recruiting
120 participants
Started: May 16, 2022 · Completed: Dec 31, 2028
1 condition
7 sponsors
4 locations
NCT05690802
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
NA
Recruiting
1,060 participants
Started: May 16, 2022 · Completed: May 30, 2029
1 condition
1 sponsor
1 location
NCT05348213
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
PHASE2
Recruiting
76 participants
Started: May 16, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05410951
LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients
N/A
Recruiting
800 participants
Started: May 16, 2022 · Completed: May 16, 2027
4 conditions
1 sponsor
1 location
Previous
1
More pages
988
989
990
991
992
993
994
More pages
1333
Next